Stability Studies Conference Ireland 2026

Dr. Mark Powell is a Fellow of the Royal Society of Chemistry (RSC) with over thirty years’ experience as a senior analytical chemist. Mark has served as both Honorary Secretary and Honorary Treasurer of the RSC’s Analytical Division and led a working group on continuing professional development until July 2016. He has worked at a senior level in a number of companies with responsibility for analytical development and equipment qualification.

In 2010 Mark was appointed Scientific Manager of a UK-based pharmaceutical CRO, with responsibility for guiding the direction of drug development programmes as well as establishing collaborations with academia and instrument manufacturers. In 2013, he set up his own company to provide training and consultancy services to the pharmaceutical industry. His consultancy work has involved, amongst other things, managing the analytical aspects of pharmaceutical development programmes and conducting data integrity audits.

He is in demand as a trainer in topics such as chromatography, spectroscopy, dissolution testing, data integrity, control of impurities, technical writing, stability/stress studies, method validation, extractables and leachables, and root cause analysis.

Stephen Delaney has been a driving force behind Q1 Scientific’s growth and success since joining the company in 2016. Appointed CEO in 2018 and later Managing Director in 2022, he has led the organization through a period of significant expansion, innovation, and industry recognition.

Under Stephen’s leadership, Q1 Scientific has achieved numerous accolades, including Contract Services Company of the Year at the Pharma Industry Awards in 2020, Business of the Year at the Waterford Chamber Business Awards in 2021, and most recently, the prestigious Operational Excellence Award at the Pharma Industry Awards 2025. This latest recognition reflects Q1 Scientific’s unwavering commitment to quality, continuous improvement, and delivering exceptional service to customers across the global pharmaceutical and life sciences industries.

A passionate advocate for growth and innovation, Stephen led the expansion of Q1 Scientific’s Waterford headquarters, transforming the facility into a state-of-the-art pharmaceutical stability storage hub spanning more than 30,000 square feet. He also oversaw the launch of the company’s European facility in Liège, Belgium, significantly enhancing support for customers across mainland Europe through increased stability storage capacity and advanced temperature-controlled logistics solutions.

Building on this momentum, Stephen led the opening of Q1 Scientific’s third facility in Durham, North Carolina, further strengthening the company’s global footprint and expanding its environmentally controlled stability storage capabilities for pharmaceutical, medical device, and life sciences organizations throughout North America.

As Managing Director, Stephen plays a critical role in supporting the R&D supply chain for new medicinal products and devices. His strategic leadership ensures that Q1 Scientific continues to provide reliable, cGMP-compliant temperature-controlled stability storage solutions that meet the exacting standards of the world’s leading pharmaceutical and medical device companies.

Stephen holds a degree in Materials Technology and Engineering from the University of Limerick and a Master’s degree in Business Management from the Smurfit Graduate Business School.

Patricia is Associate Director and Senior Consultant in Ireland for Orion GxP Consulting and heads up GMP and GDP operations for multinational Irish clients. In her role, she has built a strong relationship with the compliance team in the HPRA in Ireland, with a clear understanding of the applications of regulation and guidelines. Patricia has attended many inspections and enjoys the challenge of always being inspection ready. She has a Passion for Quality and the Pharmaceutical World, with a particular interest in Supply Chain where Patricia has 31 years of experience. This has provided job satisfaction as she works to the mantra of putting the patient at the heart of everything we do. Patricia works tirelessly to mitigate risk and deliver medicine to patients that meets the highest levels of quality, safety and efficacy.

She has a Bachelor of Art In Pharmaceutical Business Operations, a Post Grad Certificate in Clinical Research and a Master of Science In Pharmaceutical Manufacturing Technology from Trinity College Dublin.

Aideen Glynn is a highly experienced Quality Manager at Q1 Scientific, with over 18 years’ experience in the pharmaceutical industry. Since joining Q1 Scientific in March 2024, Aideen has played a key role in overseeing quality assurance and regulatory compliance across Q1 Scientific’s global network of stability storage facilities located in Ireland, Belgium, and the United States.

Before joining Q1 Scientific, Aideen held senior roles in Quality Control and Quality Assurance at EirGen Pharma, Nypro Healthcare, and Newport Synthesis. Her background includes managing stability programs, conducting audits, and ensuring compliance across a range of pharmaceutical and healthcare operations.

Aideen holds a Postgraduate Diploma in Quality Management from Technological University Dublin and a BSc in Analytical Science from Dublin City University. She’s also certified in Good Distribution Practice, Pharmaceutical Auditing, and is a qualified QMS Lead Auditor.

At Q1 Scientific, Aideen plays a key role in helping clients prepare for and respond to stability-related disruptions. Whether it’s a chamber failure, a natural disaster, or a supply chain interruption, Aideen works closely with clients to protect critical samples and ensure stability studies continue uninterrupted through secure, validated backup storage solutions.